0002038848-24-000001.txt : 20241001 0002038848-24-000001.hdr.sgml : 20241001 20241001134708 ACCESSION NUMBER: 0002038848-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241001 DATE AS OF CHANGE: 20241001 EFFECTIVENESS DATE: 20241001 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Radiant Biotherapeutics Inc. CENTRAL INDEX KEY: 0002038848 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-525543 FILM NUMBER: 241342433 BUSINESS ADDRESS: STREET 1: 3, PLACE VILLE-MARIE STREET 2: SUITE 12350 CITY: MONTREAL QC STATE: Z4 ZIP: H2B 0E7 BUSINESS PHONE: 514-298-4222 MAIL ADDRESS: STREET 1: 3, PLACE VILLE-MARIE STREET 2: SUITE 12350 CITY: MONTREAL QC STATE: Z4 ZIP: H2B 0E7 D 1 primary_doc.xml X0708 D LIVE 0002038848 Radiant Biotherapeutics Inc. 3, Place Ville-Marie Suite 12350 Montreal QC Z4 CANADA (FEDERAL LEVEL) H2B 0E7 514-298-4222 QUEBEC, CANADA None None Corporation true 2020 Arthur Fratamico 3, Place Ville-Marie Suite 12350 Montreal QC Z4 CANADA (FEDERAL LEVEL) H3B 0E7 Executive Officer Promoter Biotechnology Decline to Disclose 06b false 2024-08-27 false true false 499997 34299986 34299986 0 false 7 0 0 0 false Radiant Biotherapeutics Inc. Arthur Fratamico Arthur Fratamico Chief Executive Officer of the Issuer 2024-10-01